The aryl hydrocarbon receptor (AHR) repressor (AHRR) has been recognized as a negative feedback modulator of AHRmediated responses in fish and mammals. However, the repressive mechanism by the AHRR has not been investigated in other animals. To understand the molecular mechanism of dioxin toxicity and the evolutionary history of the AHR signaling pathway in avian species, the present study addresses chicken AHRR (ckAHRR). The complementary DNA sequence of ckAHRR encodes an 84-kDa protein sharing 29-52% identities with other AHRRs. High levels of ckAHRR messenger RNA were recorded in the kidney and intestine of nontreated chicks. In hepatoma LMH cells, the 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) 50% effective concentration value for ckAHRR induction (0.0016nM) was the same as that for chicken cytochrome P450 1A5 (ckCYP1A5), implying a shared transcriptional regulation of ckAHRR and ckCYP1A5 by chicken AHR (ckAHR). In ckAHRR transient transfection assays, ckAHRR repressed both ckAHR1-and ckAHR2-mediated transcriptional activities. Deletion and mutation assays revealed that basic helix-loop-helix/Per-ARNTSim A domains of ckAHRR, particularly 217-402 amino acid residues, are indispensable for the repression, but the AHR nuclear translocator sequestration by ckAHRR and SUMOylation of ckAHRR are not involved in its repressive mechanism. Additionally, subcellular localization assay of ckAHR1-enhanced green fluorescent protein fusion protein showed that ckAHRR did not affect nuclear translocation of the ckAHR1. Furthermore, ckAHRR inhibited the TCDD-and 17b estradiol-enhanced ckCYP1A5 transcription through AHR-estrogen receptor a (ERa) cross talk. Taken together, the function of AHRR is conserved in chicken in terms of the negative regulation of AHR and ERa activities, but its functional mechanism is likely distinct from those of the mammalian and fish homologues.
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Key Words: aryl hydrocarbon receptor repressor; aryl hydrocarbon receptor; 2, 3, 7, chicken. Many adverse effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds occur through altered expressions of known and unknown target genes that are mediated by aryl hydrocarbon receptor (AHR) (Bunger et al., 2003; Nebert et al., 2004) . The mechanism of transcriptional activation by TCDD-bound AHR has been extensively characterized. Upon its ligand binding, the AHR translocates into the nucleus from cytosol, dimerizes with the AHR nuclear translocator (ARNT) in the nucleus, and the AHR-ARNT complex binds to DNA response elements (known as a xenobiotic-responsive element, XRE) located in the promoter region of target genes including cytochrome P450 1A (CYP1A). Following the subsequent recruitment of coactivators such as receptor interacting protein 140 and the histone acetyltransferase, p300/CBP (Mimura and Fuji-Kuriyama, 2003) , the AHR-ARNT complex induces the transcription of the target genes.
Besides the upregulation mechanism of AHR-mediated transactivation, there are several proposed mechanisms on the downregulation. One of the mechanisms is the transcriptional repression of AHR target genes by the AHR repressor (AHRR) (Haarmann-Stemmann and Abel, 2006; Mimura et al., 1999) . In transient transfection assays, AHRR exhibited repression activity in AHR-dependent transactivation of CYP1A that was induced by TCDD (Evans et al., 2005; Karchner et al., 2002; Mimura et al., 1999; Zimmermann et al., 2008) . In addition, AHRR was transcriptionally induced by ligand-activated AHR in vivo and in vitro (Evans et al., 2005; Hanno et al., 2010; Roy et al., 2006) via XREs located in the promoter region of AHRR (Karchner et al., 2002) . Hence, TCDD-induced expression of AHRR and CYP1A and the following repression of induced CYP1A transactivation by AHRR imply the existence of a negative feedback loop of AHR signaling pathway by AHRR.
AHRR belongs to the basic helix-loop-helix/Per-ARNT-Sim (bHLH/PAS) protein family together with AHR and ARNT. Through the conserved functional domains, AHRR can dimerize with ARNT and the AHRR-ARNT complex can bind XREs (Karchner et al., 2002; Mimura et al., 1999) . However, being different from AHR, AHRR shows no ligand-dependent activation for dimerization with ARNT and XRE binding (Karchner et al., 2002) . Based on these properties, Mimura et al. (1999) proposed two repression mechanisms by AHRR. One is that AHRR competes with AHR for heterodimerization with ARNT, and the sequestration of ARNT by AHRR causes deficiency of ARNT for AHR-ARNT complex formation. The other mechanism is the competition between AHRR-ARNT and AHR-ARNT complexes for binding to XREs. Moreover, it was recently reported that the modification (SUMOylation) of C-terminus in mouse AHRR (mAHRR) by the small ubiquitinrelated modifier (SUMO) markedly enhances the interaction of AHRR with histone deacetylase (HDAC) 4, HDAC 5, and ankyrin-repeat protein (ANKRA) 2, suggesting that SUMO modification can regulate AHRR activity through the modification of chromatin structure and C-terminal region of AHRR is a critical site for its repression activity (Oshima et al., 2009) . On the other hand, zebrafish AHRR study suggested that repression mechanism may involve competition for coactivators between AHR and AHRR, but not ARNT and XRE binding. It was also reported that the N-terminus but not Cterminus of AHRR is indispensable for the repression activity of AHRR (Evans et al., 2008) . The reason of this discrepancy between mAHRR and zebrafish AHRR remains obscure, but it cannot be ruled out that there are interspecies differences in the molecular mechanisms of AHRR-mediated repression of AHR signaling.
Recent intensive studies revealed that direct interaction between AHR and estrogen receptor a (ERa) is involved in AHR-ERa cross talk mechanism (Ohtake et al., 2007 (Ohtake et al., , 2009 ). Suppression of ERa-mediated transactivation by AHRR has also been demonstrated in human breast cancer MCF-7 cells. Mechanistically, it was proposed that AHRR represses ERa activity through direct interaction with ERa (Kanno et al., 2008) . Given these findings, further investigations on the effect of AHRR on AHR-ERa cross talk in other model animals would allow for a better understanding of the role in AHRR.
In the present study, chicken (Gallus gallus) AHRR (ckAHRR) was initially cloned and sequenced. Following the molecular characterization of ckAHRR, the functional analysis was conducted to understand the negative regulatory mechanism of the AHR-mediated signaling pathway and the association of AHRR with AHR-ERa cross talk in the avian species.
MATERIALS AND METHODS
Animals and cells. White leghorn chickens (G. gallus) and eggs were obtained from Freshfood Farm, Inc. (Matsuyama, Japan). For determining the tissue distribution of ckAHRR, the liver, muscle, kidney, heart, brain, intestine, lung, stomach, and eyeball were immediately removed from two male and two female chicks at posthatching days 2 and frozen in liquid nitrogen. The dissected tissues were stored at À80°C in the laboratory until total RNA isolation. Kidneys were used for ckAHRR complementary DNA (cDNA) cloning. Fertilized eggs of one embryonic day were used for in ovo TCDD injection experiment. The chicks and embryos were sacrificed according to the Regulation of Animal Experiments of Ehime University. Chicken hepatoma LMH cells were obtained from ATCC (Manassas, VA). African green monkey kidney fibroblast cells (COS-7) were kindly provided by Prof Kyu-Hyuck Chung (University of Sungkyunkwan, Korea).
Oligonucleotide primers and probes. All primers and probes were synthesized by Hokkaido System Science (Sapporo, Japan). The sequences of primers and probes used for the cloning of AHRR cDNA and for the quantification of AHRR and CYP1A5 messenger RNAs (mRNAs) are listed in Table 1 .
Cloning and sequencing of ckAHRR cDNA. For the cloning of ckAHRR cDNA, total RNA was isolated from kidneys of two chicks using FastPure RNA Kit (Takara). Poly(A) þ RNA from total RNA was purified by Oligo (dT)
Spin Columns (Amersham Biosciences). The kidney mRNA was reverse transcribed using random hexamer as a primer and Murine Leukemia VirusReverse Transcriptase (MLV-RT) (Promega) under the following temperature conditions: 1 cycle of 10 min at 25°C, 15 min at 42°C, and 5 min at 99°C. Two cDNA fragments of ckAHRR (one contains 5#-terminal and the other contains 3#-terminal) that can totally cover the full open reading frame were amplified using the Marathon cDNA Amplification Kit (Clontech) with 10lM of each primer set (full-ckAHRR-F1/full-ckAHRR-R1 and full-ckAHRR-F2/fullckAHRR-R2) that were designed from deposited ckAHRR sequences in Ensembl (www.ensembl.org). The temperature condition of polymerase chain reaction (PCR) was as follows: 30 s at 94°C, 5 cycles of 5 s at 94°C and 4 min at 67°C, 5 cycles of 5 s at 94°C and 4 min at 65°C, and 25 cycles of 5 s at 94°C and 4 min at 60°C for the full-ckAHRR-F1/full-ckAHRR-R1 set, and 30 s at 94°C, 5 cycles of 5 s at 94°C and 2 min at 63°C, 5 cycles of 5 s at 94°C and 2 min at 60°C, and 25 cycles of 5 s at 94°C and 2 min at 53°C for the fullckAHRR-F2/full-ckAHRR-R2 set. The nucleotide sequences were cloned into pGEM-T Easy vector (Promega) and were sequenced with ABI PRISM 310 genetic analyzer (Applied Biosystems).
Sequence alignment and phylogenetic analysis. Multiple alignments of AHRR amino acid sequences were performed by using CLUSTAL_W version 1.7. The aligned amino acid sequences were used to construct the phylogenetic tree with the neighbor joining method using MacVector 7.l program.
Quantitative PCR. For the quantification of ckAHRR mRNA in various tissues from two male and two female chicks and of ckAHRR and CYP1A5 mRNAs in chicken hepatoma LMH cells and in the liver of embryos exposed to TCDD, two-step real-time PCR method was applied (Lee et al., 2007) . Total RNAs were isolated using FastPure RNA Kit. To avoid the DNA contamination, the RNA samples were treated with DNase. The yield of RNA was confirmed spectrophotometrically. Reverse transcription and subsequent real-time PCR were performed using High-Capacity cDNA Archieve Kit (Applied Biosystems) and Taqman PCR Reagent Kit with AmpliTaq Gold DNA Polymerase (Applied Biosystems), respectively. Serially diluted plasmids containing cDNA fragment of ckAHRR were prepared as standard solutions for quantification of ckAHRR mRNA expression. The primer and probe sequences for real-time PCR are listed in Table 1 . The thermal cycling is comprised of an initial step at 50°C for 2 min, followed by a denaturation step at 95°C for 10 min, and 40 cycles of 15 s at 95°C and 1 min at 60°C. The ckAHRR mRNA expression level was normalized to 18S ribosomal RNA content and was calculated as described in Lee et al. (2007) . The equation for the calculation was as follows: [Quantity (g) of target gene per 1 ng of total RNA/rRNA 3 Avogadro's number]/(molecular weight of vector þ molecular weight of the inserted DNA) ¼ vector count per 1 ng of total RNA/rRNA.
In ovo and in vitro exposure to TCDD. Chicken eggs of 1 embryonic day were treated with vehicle control (dimethyl sulfoxide [DMSO]/toluene ¼ 9/1), 1, 10, or 100 pg/g egg of TCDD solution. Eleven to 16 eggs were employed for 320 each dose. Prior to the injection, eggs were weighed and small holes were drilled on the eggshell above air sac at the blunt end of the egg. Vehicle or TCDD solution was injected into the air sac using a microsyringe. The injection volume of vehicle or TCDD solution was adjusted to about 10 ll per egg, determining the final concentration of TCDD in each treated group. Following vehicle or TCDD injection, the holes on the eggshell were sealed with paraffin wax, and the eggs were placed in an incubator with an automatic egg turner set (1 rolling per hour), keeping the incubator conditions at 37.5°C and 55% humidity. Chicken embryos were sacrificed before hatching at the 20th embryonic day. The livers from the embryos in each treatment group were removed, pooled, and immediately frozen in liquid nitrogen. The samples were stored at À80°C in the laboratory until total RNA isolation.
For in vitro experiments, LMH cells were treated with DMSO or a serially diluted TCDD solution from 14 to 0.00014nM for overnight, and then total RNA was isolated from the treated cells for the quantification of ckAHRR and ckCYP1A5 mRNAs.
Plasmid construction. The expression plasmids of chicken AHRs (ckAHRs) and ARNTs (ckARNTs), pcDNA-ckAHR1, -ckAHR2, -ckARNT1, and -ckARNT2, and the firefly luciferase reporter vector containing chicken CYP1A5 (ckCYP1A5) promoter region, pGL4-ckCYP1A5-6XREs, were described elsewhere (Lee et al., 2009 , Lee et al., 2010 , Yasui, 2007 .
For ckAHRR transient transfection assay, the expression plasmid of ckAHRR (pcDNA-ckAHRR) was generated. Each fragment that was amplified by PCR using two sets of primer pairs (full-ckAHRR-F1/-R1 and fullckAHRR-F2/-R2) was inserted into pGEM-T Easy vector and designated as pGEM-ckAHRR-5# and pGEM-ckAHRR-3#, respectively. To construct the pGEM-T Easy vector with full-length ckAHRR (pGEM-ckAHRR-full), pGEMckAHRR-3# was digested with HindIII and SpeI and ligated into the same restriction enzyme sites of pGEM-ckAHRR-5#. For the construction of pcDNA-ckAHRR, the 5#-terminal NotI site originated from pGEM-T Easy vector in pGEM-ckAHRR-full was mutated to XhoI site using QuickChange II Site-Directed Mutagenesis Kit (Stratagene). The mutated vector was digested with XhoI and NotI, and the fragment was ligated into pcDNA3.1/Zeo (À) (Invitrogen).
To construct expression plasmids of ckAHRR for deletion assays, one BamHI site was inserted into the deleted site of pcDNA-ckAHRR using QuickChange II Site-Directed Mutagenesis Kit (Supplementary fig. S2 ). The NheI/BamHI fragment from this plasmid was then inserted into the corresponding sites of pcDNA-ckAHRR. For mutation assays, lysine (AAA or AAG) in SUMOylation consensus sites was mutated to arginine (AGG or AGA) by generating point mutations from pcDNA-ckAHRR using QuickChange II Site-Directed Mutagenesis Kit.
For the expression of ckAHRR as an N-terminal FLAG tag fusion protein, FLAG and 3xFLAG fragments were amplified with NheI site-inserted forward primer (pFLAG-NheI-F) and reverse primer (pFLAG-R) using pCMV-FLAG and pCMV-3xFLAG plasmids (Sigma) as templates. Amplicons including 1xFLAG and 3xFLAG were digested with NheI and XbaI and then inserted into the same sites of pcDNA-ckAHRR. The pcDNA-ckAHRR vectors with 1xFLAG and 3xFLAG were designed as pcDNA-FLAG-ckAHRR and pcDNA3xFLAG-ckAHRR, respectively. These expression vectors were transfected into LMH cells.
Enhanced green fluorescent protein (EGFP)-tagged ckAHR1 plasmid was constructed from pCXN2-EGFP that was kindly gifted by Prof Ichiro Miyoshi, Nagoya City University, Japan (Niwa et al., 1991) . Initially, PCR-amplified EGFP cDNAs (720 bp) were inserted in the pGEM-T easy vector, and the inserted vector was digested with SpeI and NotI. Using pcDNA-ckAHR1 as a template, full-length ckAHR cDNA was amplified with pcDNA T7 promoter forward primer and a reverse primer, ckAHR1-R-full-SpeI (5#-ACTAGTCA-TAAATCCACTAGATGCC-3#). The PCR amplicon was then digested with KpnI and SpeI, by which the stop codon of ckAHR1 cDNA was replaced by SpeI site. To make EGFP fused at C-terminal position (SpeI site) of ckAHR1, the ckAHR1 cDNA that was digested with KpnI/SpeI was ligated with EGFP cDNA fragment. The ligated ckAHR1-EGFP fragment was inserted into KpnI/ NotI sites of pCXN2-EGFP (pCXN2-ckAHR1-EGFP).
Full-length chicken ERa (ckERa) was amplified using a primer set of fullckERa-F and full-ckERa-R with cDNA fragments constructed from LMH cells as a template and cloned into pGEM-T Easy vector (pGEM-ckERa). The 5#-terminal NotI site originated from pGEM-T Easy vector in pGEM-ckERa was mutated to XhoI site using QuickChange II Site-Directed Mutagenesis Kit. This plasmid was cut by XhoI and NotI and ligated into pcDNA3.1/Zeo (À) (pcDNA-ckERa). The ER-responsive reporter vector, pGL3-ERE-LUC, was kindly gifted by Prof Shigeaki Kato, the University of Tokyo (Ohtake et al., 2003) .
Whenever the target fragments were generated by PCR, the amplicons were verified by sequencing. All primers used for the plasmid construction are represented in Table 1 .
Cell cultures. COS-7 cells that are known to contain trace amounts of endogenous AHR were maintained in Dulbecco's modified Eagle's medium (DMEM, Sigma) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (FBS, HyClone), 100 U/ml penicillin, and 100 lg/ml streptomycin in a humidified 95% air/5% CO 2 at 37°C. LMH cells were maintained at 37°C with CO 2 in Waymouth's MB 752/1 medium (Invitrogen), supplemented with 100 U/ml penicillin, 100 lg/ml streptomycin, and 10% FBS. Both cells in monolayer culture were routinely passaged with trypsin/ EDTA twice per week.
Transient transfections and luciferase reporter gene assays. For the functional analysis of ckAHRR, wild-type, deleted, or mutated ckAHRR was transfected into COS-7 and LMH cells. Transfection methods have been described previously (Lee et al., 2009) . In brief, 6 3 10 4 cells per well of COS-7 cells and 5 3 10 5 cells per well of LMH cells were seeded onto 24-well plates (Nunc) and gelatin-coated 24-well plates (Iwaki), respectively, cultured for 24 h, and transfected with Lipofectamine LTX (Invitogen) in Opti-MEM I medium (Invitrogen) according to the manufacturer's instructions. For the transfection of expression plasmids (pcDNA-ckAHR1, -ckAHR2, -ckARNT1, -ckARNT2, -ckERa, and/or -ckAHRR), the amounts indicated in each figure were applied. As firefly luciferase reporter plasmids, 20 ng of pGL4-ckCYP1A5-6XREs for COS-7 cells or 40 ng for LMH cells, and 3 ng of Renilla luciferase plasmid (pGL4.74[hRLuc/TK]) (Promega) as a control for measuring transfection efficiency were transfected. The plasmid amount per one well was adjusted to 300 ng using pcDNA plasmid with no insert. After 5 h incubation, the media were exchanged with dextran-coated charcoal (DCC)-stripped DMEM with DCC-stripped 10% FBS for COS-7 cells (or with DCC-stripped Waymouth's MB 752/1 with DCC-stripped 10% FBS for LMH cells). DMSO, TCDD, and/or 17b-estradiol (E2) were added to the cells. After 18 h exposure, cells were washed once with cold PBS and lysed with 13 passive lysis buffer. Luciferase activities derived from the transactivation of ckCYP1A5-6XREs were determined using a dual luciferase assay kit (Promega) according to the manufacturer's instructions. Lysates were maintained at À80°C prior to the measurement of luciferase activity using a GloMax 96 Microplate luminometer (Promega). The final luminescence values were expressed as a ratio of the firefly luciferase unit to the Renilla luciferase unit (relative luciferase unit). Each treatment group was plated in triplicate, and the experiment was repeated at least two times.
Western blot analysis. About 5 3 10 6 LMH cells were plated in gelatincoated 100-mm dishes (Iwaki) and incubated for 24 h. Cells were washed with Opti-MEM I, and 3 lg of pcDNA-FLAG-empty (negative control), pcDNA-FLAG-ckAHRR, and pcDNA-3xFLAG-ckAHRR or its deletion mutants were transfected using Lipofectamine LTX in Opti-MEM I medium. Following incubation for 24 h, cells were rinsed with cold PBS, harvested with 1 ml PBS using a cell scraper, and transferred to a microcentrifuge tube. After the collection of cells by centrifugation, supernatant was removed and total protein was extracted in 300 ll of cold RIPA buffer (1% nonyl phenoxypolyethoxylethanol 40, 0.1% SDS, 0.5% sodium deoxycholate, 1mM sodium orthovanadate, and protease inhibitor cocktail [Promega] in PBS). Measurement of protein concentration was performed using BCA Protein Assay Kit (Pierce). After adjusting the amount of protein among samples using RIPA buffer, samples were diluted and denatured with 43 SDS sample buffer with boiling for 5 min. Proteins were fractionated by SDS-polyacrylamide gel MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF CHICKEN AHRR electrophoresis and electrophoretically transferred to a polyvinylidene fluoride membrane. Blots were blocked for 60 min in Tris-buffered saline with 0.1% Tween 20 (TBS-T) containing 5% nonfat dried milk and were then incubated with an anti-FLAG monoclonal antibody (Sigma) in TBS-T containing 5% nonfat dried milk overnight at 4°C. Following washing in TBS-T, a horseradish peroxidase-conjugated secondary antibody was incubated for 60 min in TBS-T containing 5% nonfat dried milk. Membranes were then washed in TBS-T. Emerged bands on the membrane were visualized using ECL Plus Western Blotting Detection System (Amersham Biosciences) and the imaging analyzer, ChemiDoc (Bio-Rad Laboratories).
Electrophoretic mobility shift assay. ckAHRR and ckARNT proteins in vitro translated using T N T Quick-Coupled Reticulocyte Lysate System (Promega) were incubated at 4°C for 40 min with 10 ll of 25mM Tris-HCl buffer solution, pH 7.9, containing 25mM NaCl, 0.5mM dithiothreitol, 1mM EDTA, 1mM MgCl 2 , 10% glycerol, and poly dI-dC (0.4 lg). Double-stranded fragments containing the consensus XRE sequence (ckXRE2) of the ckCYP1A5 promoter (Lee et al., 2009) were labeled with [c-32 P]ATP (3000 mCi/mmol). After adding the approximately 70,000 cpm of the 32 P-labeled XRE probe, the mixture was incubated at 4°C for 20 min. To certify the specificity of binding of ckAHRR and ckARNT proteins to the labeled XRE probe, a 100-fold molar excess of unlabeled XRE probe was added. To separate the XRE-protein complex from the free XRE, the mixture was subjected to electrophoresis on Novex DNA Retardation Gels (Invitrogen) under nondenaturing conditions. The gels were dried and autoradiographed with intensifying screens at À70°C. Subcellular localization of ckAHR1. In a 24-well plate, COS-7 cells were grown to about 70% confluence before transfection. Following an overnight incubation, cells were transfected with 300 ng of ckAHR1 (pCXN2-ckAHR1-EGFP) and 50 ng of pcDNA-ckARNT1, with or without 100 ng of pcDNAckAHRR in Opti-MEM I medium using Lipofectamine LTX. To confirm the effectiveness of ckAHRR as a repressor of ckAHR1-mediated responses, pGL4-ckCYP1A5-6XREs as a luciferase reporter vector was also transfected with a transfection control vector, Renilla luciferase plasmid. After 5 h, cells were treated with DMSO or 3-methylcolanthrene (3-MC) and a final concentration of 1lM in DMEM with 10% FBS for 12 h. The ckAHR1-EGFP protein expressed in COS-7 cells was visualized using TE300 fluorescence microscope (Nikon) with color-chilled 3CCD camera C5810 (Hamamatsu). Luciferase activity was measured in the same plates as those run in parallel for the subcellular localization of ckAHR1-EGFP protein.
Statistical analyses. Data are expressed as mean values ± SD. Statistical analyses were performed using SPSS version 12.0 (SPSS Japan Inc.). Significance of differences in reporter gene activities was analyzed by oneway ANOVA and subsequently by Student's t-test when appropriate (p < 0.05). The 50% effective concentration (EC 50 ) of TCDD for the induction of ckCYP1A5 and ckAHRR genes was calculated using Prism 4 (GraphPad).
Nucleotide sequence accession numbers. The ckAHRR and ckERa sequences have been deposited in GenBank, with accession numbers HQ340610 and HQ340611, respectively.
RESULTS

Sequence Alignment and Phylogenetic Analysis
To isolate AHRR cDNA sequence (ckAHRR) from the chicken, we designed primers, full-ckAHRR-F1/-R1 and fullckAHRR-F2/-R2 (Table 1) , using the genomic database from Ensembl (www.ensembl.org). The resulting ckAHRR cDNA amplified by PCR encodes a protein of 756 amino acids with a molecular mass of approximately 84 kDa (Fig. 1) . The deduced amino acid sequence shares 29-52% identities overall with those of AHRRs that have been so far reported (Table 2 [A]) and contains highly conserved functional domains (bHLH and PAS A) in N-terminal region as observed in chicken and mouse AHR1s and other vertebrate AHRRs (Fig. 1, Table 2 [B]). In contrast, both the region in ckAHRR corresponding to the ligand-binding domain (LBD) of AHR and C-termianl region beyond LBD are poorly conserved with the AHR1s (36-37% and 11-12% identities, respectively) and other AHRRs (20-49% and 11-15% identities, respectively), implying no ligand-binding capacity of ckAHRR and no conservation of C-terminal-mediated transactivation among species. A previous study directly assessed the ability of AHRR to bind TCDD using a sucrose gradient assay with radiolabeled TCDD and revealed that human, mouse, and killifish AHRRs are not capable of TCDD-specific binding (Karchner et al., 2002) . Phylogenetic analysis placed the ckAHRR sequence in the same clade as other AHRR sequences. This AHRR clade is distinct from the previously identified AHR1 and AHR2 clades but is still within the larger clade of AHR family (Fig. 2 ). This suggests a potential role of ckAHRR as a modulator of AHR-mediated signaling pathways.
Tissue Distribution of ckAHRR mRNA
The constitutive expression of ckAHRR mRNA was analyzed using quantitative real-time PCR in various tissues from two male and two female chicks (Fig. 3) . The tissue distribution patterns were not different between males and females although higher AHRR expression in male than that in female was observed. High levels of ckAHRR transcript were recorded in the kidney, intestine, eye, brain, and stomach. The liver, muscle, heart, and lung showed poor or negligible expression. Interestingly, the tissue distribution pattern of ckAHRR was similar to that of ckARNT2, which was abundant in the brain, kidney, and eye but poor in the liver, muscle, heart, and lung (Lee et al., 2010) . Distribution of constitutive AHRR expression has been studied in various tissues of vertebrates including the human, rat, mouse, and fish (Bernshausen et al., 2006; Haarmann-Stemmann and Abel, 2006; Karchner et al., 2002; Korkalainen et al., 2004; Nishihashi et al., 2006; Yamamoto et al., 2004) . The expression of the AHRR mRNA was detected in all tissues of above species, which was in agreement with our data, although the tissue distribution profile was markedly different between the species.
In Ovo and In Vitro ckAHRR mRNA Induction by TCDD
To investigate the effects of TCDD on transcriptional regulation of ckAHRR, TCDD was injected into chicken eggs and ckAHRR mRNA expression level was quantified with realtime PCR. The mRNA of ckCYP1A5, which is TCDD inducible via functional XREs in its promoter region (Lee et al., 2009) , was also measured as a positive control. As shown in Figure 4 , ckAHRR was induced by TCDD in a dosedependent manner. The induction pattern was similar to that 322 observed in ckCYP1A5. More precisely, to compare the effect of TCDD on the transactivation between ckAHRR and ckCYP1A5, chicken hepatoma LMH cells were employed and TCDD-EC 50 value for each gene was estimated. The endogenous ckAHRR and ckCYP1A5 in LMH cells were transcriptionally induced by TCDD and the TCDD-EC 50 for ckAHRR expression was 0.0016nM, which was the same value as that for ckCYP1A5, although the maximum fold induction of ckAHRR (threefold) in response to TCDD over control was smaller than that of ckCYP1A5 (10-fold) (Fig. 5) .
Repression of AHR-Mediated Reporter Activity in Response to TCDD by ckAHRR
To determine the effect of ckAHRR on ckAHR-mediated transactivation, expression plasmid of ckAHRR (pcDNAckAHRR) was cotransfected into LMH cells with a reporter vector, pGL4-ckCYP1A5-6XREs containing 5#-flanking region of ckCYP1A5 (Fig. 6A) . The reporter activity was induced in response to TCDD through endogenous ckAHRs and ckARNTs (Fig. 6A, lane 1) , and the enhanced activity was inhibited by overexpressed ckAHRR (Fig. 6A, lanes 2-5) , indicating the repression of TCDD-inducible ckCYP1A5 transcriptional activity by ckAHRR. Moreover, TCDD-induced reporter expression was strengthened by cotransfection with exogenous ckAHR1, and the activity was also repressed by the introduction of ckAHRR (Fig. 6A, lane 6 vs. lane 7) . Repressive effect of ckAHRR on each ckAHR1-and ckAHR2-mediated luciferase activity was also investigated using COS-7 cells (Fig. 6B) . The ckAHR1-or ckAHR2-containing vector was cotransfected with ckARNT1 and For cloning of ckAHRR cDNA,
GGGGCTCACGCCTGATTGCCTGAACCAAG For amplification of FLAG sequence from pCMV-FLAG and pCMV-3xFLAG, pFLAG-NheI-F TAAGCAGAGCTAGCTTAGTGAACC pFLAG-R CCCGGGATCCTCTAGAGTCGACTG Note. The start codon, ATG and stop codon, TAG and TAA (CTA and TTA as reverse primer sequences, respectively) are indicated with bold. The inserted restriction enzyme site is underlined. The SUMOylation consensus site is underlined, and lysine to arginine mutation is indicated in bold underlined. F, forward; R, reverse.
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pGL4-ckCYP1A5-6XREs. The increased activity mediated by ckAHR1 in a TCDD-dependent manner was suppressed by ckAHRR (Fig. 6B, lane 2 vs. lanes 3-5) . Interestingly, ckAHRR also inhibited the luciferase activity that was constitutively elevated by ckAHR2 regardless of TCDD treatment (Fig. 6B, lane 6 vs. lanes 7-9) .
FIG. 1.
Comparison of AHRR and AHR1 amino acid sequences from the chicken and other vertebrates. Identical amino acids are boxed. The bHLH, PAS A, and PAS B regions determined by the alignment with AHR are marked by lines above the sequences. The LBD is in bracket. The sequence alignment was performed using CLUSTAL_W 1.7 alignment program. The GenBank accession numbers listed here are as follows: chicken AHR1 (AF260832), mouse AHR (M94623), chicken AHRR (HQ340610), human AHRR (ABX89616), mouse AHRR (AB015140), rat AHRR (AB174900), Xenopus laevis (X. laevis) AHRR (EU156964), killifish AHRR (AF443441), zebrafish AHRRa (AY928203), and zebrafish AHRRb (AY928204).
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N-terminal Region of ckAHRR Is Indispensable for the Repression of TCDD-Inducible Transcriptional Activity
To explore the critical region of ckAHRR required for its repression activity, deletion mutants were produced by truncating downstream region from the amino acid 217 [ckAHRR-D(217-756)], corresponding to PAS B domain of ckAHR1 and from C-terminal transactivation domain ] (Fig. 7A and Supplementary fig.  S1 ). The expressions of the wild-type and truncated ckAHRR proteins were verified through transfection of each FLAGtagged expression construct into LMH cells. The FLAG was immunochemically detected with Western blot because of no commercially available antibody against ckAHRR. Each protein derived from wild-type and the deletion mutant constructs was observed at the predicted size (Fig. 7B) . The wild-type ckAHRR reduced TCDD-induced luciferase activity in the same manner as shown in Figure 6A , and ckAHRR-D(403-756) mutant also exhibited similar repression with the wild type (Fig. 7C) . This indicates that the deleted C-terminal region is not critical for the repression activity of ckAHRR. On the other hand, ckAHRR-D(217-756) mutant mostly lost its repression activity. To rule out the possibility that loss of activity of ckAHRR-D(217-756) is caused by insufficient expression for its repression, the mutant constructs, from 10 to 200 ng of ckAHRR-D(403-756) or 200 to 600 ng of ckAHRR-D(217-756), were transfected into LMH cells and the repression activity depending on the transfected amount of the constructs was investigated (Fig. 7D) . The TCDD-induced luciferase activity gradually reduced with an increasing amount of ckAHRR-D(403-756) (Fig. 7D, lanes 2-5) . In contrast, even when an increasing amount of ckAHRR-D(217-756) construct was applied, no significant change in reporter activity was observed (Fig. 7D, lanes 6-8) . Similar results were also obtained from experiments using COS-7 cells; the ckAHRR-D(217-756) form, a deleted mutant from amino acid 217 to 402, completely lost the repressor activity (Fig. 7E, lane 4 
vs. lane 5).
Mechanism of ckAHRR-Mediated Repression of AHR Activity
Induced by TCDD Because AHRR is known to be able to dimerize with ARNT, it has been hypothesized that the mechanism on suppression of AHR/ARNT-mediated response by AHRR involves the competition between AHR and AHRR for the dimerization with ARNT (Mimura et al., 1999) . To examine the potential for ARNT sequestration by AHRR in the repression mechanism, dimerization of ckAHRR with ckARNT1 or ckARNT2 and DNA binding were verified by gel mobility shift assays. As predicted, ckAHRR could interact with both ckARNT isoforms and bind to XRE without TCDD treatment (Fig. 8A) . It is consistent with ligand independency for its functional activation shown in other verterbrate AHRRs. In addition, the deletion mutant, ckAHRR-D(403-756), which showed a similar repressive effect to wild-type ckAHRR (Fig. 7C) , was also able Note. Aligned regions are from 10 to 78 for the DNA-binding domain, from 132 to 189 for the PAS A, and from 236 to 395 for the LBD of chicken AHR1. Gaps were excluded for the alignment calculations. Accession numbers of AHRs and AHRRs used are listed in Figure 1 .
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to bind to XRE in an ARNT-dependent manner (Fig. 8B) . The specific XRE binding of the ckAHRR-ckARNT complex was confirmed through disappearance of XRE-derived band by adding excess amount of unlabeled XRE probes [Fig. 8B, lane Following the gel mobility shift assays, the alleviation effect of overexpressed ckARNT1 and ckARNT2 on transactivation inhibited by ckAHRR was evaluated by the reporter gene assays for XRE-driven transactivation by endogenous ckAHRs in LMH cells (Fig. 8C) . The elevated luciferase activity by TCDD treatment was reduced by transfected ckAHRR (Fig. 8 lane 1 vs. lane 2), but overexpression of neither ckARNT1 nor ckARNT2 relieved the suppression by ckAHRR, independent on the amount of transfected ckARNT plasmids.
Recently, Oshima et al. (2009) reported that SUMO modification of three SUMOylation consensus sites located in C-terminal region of mAHRR is an important process for repression activity of AHR-mediated responses. In the deduced amino acid sequence of ckAHRR, six potential SUMOylation sites were found by SUMOsp 2.0 (software for SUMOylation sites prediction) and named as K385, K428, K437, K564, K607, and K715 in the order from N-terminus (Supplementary fig. S2 ). The K385, K428, and K437 sites are ckAHRR specific, and the other three sites are conserved in vertebrate species including the mouse. To investigate whether the regulation mechanism of mAHRR by SUMO modification is conserved in avian species, lysine (K) residue in the potential SUMOylation sites of ckAHRR was point mutated into arginine (R) by performing in vitro mutagenesis, which has the same properties with K (basic and polar) to minimize other effects caused by the amino acid substitution. The repression activity of the mutated ckAHRR construct was then compared with that of the wild type in in vitro reporter gene assay. The results showed that the repressor activity by ckAHRR in both LMH and COS-7 cells was less affected by the single and combined mutations of the SUMO sites in ckAHRR (Fig. 9, lane 2 vs. lanes 3-9) . The mutations in chickenspecific K385, K428, and K437 sites also showed no recovery of the repressed activity (data not shown). From these results, we conclude that SUMO modification of ckAHRR did not affect the repression activity.
Subsequently, we examined whether or not ckAHRR could inhibit nuclear translocation of ligand-activated ckAHR. EGFP-tagged ckAHR1 into COS-7 cells was monitored when plasmid with ckAHRR cDNA or no insert was cotransfected. In the absence of ckAHRR, ckAHR1 was distributed both in the cytoplasm and nucleus when no AHR ligand was treated 
FIG. 3.
Tissue distribution profile of ckAHRR mRNA. Total RNA in each tissue was extracted from two male and two female chicks and was reverse transcribed (see ''Materials and Methods'' section). Expression levels of mRNAs were quantified with two-step real-time PCR method. Various concentrations of plasmids where ckAHRR cDNA was inserted were used as a standard for quantifying its mRNA expression level. The expression levels were calculated as vector counts per 1 ng of total RNA normalized by rRNA. ( Figs. 10A and 10B ). Upon treatment with 3-MC, ckAHR1 was predominantly localized in the nucleus (Fig. 10C) . However, the nuclear translocation of ckAHR1 triggered by 3-MC remained unchanged when ckAHRR was cotransfected (Figs. 10C vs. 10F ).
Modulation of Cross Talk between AHR-and ERa-Mediated Signaling Pathways by ckAHRR
There are some reports indicating that ERa could affect AHR-mediated pathway in mammals (Jana et al., 1999 (Jana et al., , 2000 Son et al., 2002) . However, the occurrence of cross talk between ERa-and AHR-mediated pathways and the role of ckAHRR on the cross talk have not been investigated in avian species.
Prior to examining the interference of ERa with AHRmediated pathway, ckERa was initially cloned and its expression plasmid (pcDNA-ckERa) was constructed. In both COS-7 cells and LMH cells, transiently transfected ckERa induced the transactivation of an ERE-containing reporter gene, pGL3-ERE-LUC, in an E2-dependent manner, indicating ckERa activation by E2 and its transactivation potency (Supplementary fig. S3 ). This demonstrates the functional conservation of ckERa as has been observed in other species (Menuet et al., 2002; Stack et al., 1988) .
Following the preliminary study on ckERa, the effect of ckERa on AHR-mediated pathway was investigated in LMH cells in which ckERa expression vector was transiently transfected. The XRE-containing reporter plasmid, pGL4-ckCYP1A5-6XREs, and transfection control vector were cotransfected with pcDNA-ckERa, and DMSO (vehicle control), ER ligand (E2), AHR ligand (TCDD), or the mixture of E2 and TCDD (E2 þ TCDD) was treated. As shown in Figure 11A , lane 1, the luciferase activity induced by E2 þ TCDD mixture, was significantly higher than that by TCDD or E2 alone in ckERa-expressed LMH cells, indicating the synergistic effect of E2 and TCDD on ckCYP1A5 transcription through the cross talk between AHR-and ER-mediated pathways. Such a cross talk pathway was reported in humans, showing that E2-activated ERa potentiated AHR-regulated CYP1A1 transcription induced by TCDD in ERa-transfected HuH7 human hepatoma cells (Matthews et al., 2005) . The authors suggested that ERa could positively modulate AHR   FIG. 4 . Inducibility of hepatic ckCYP1A5 and ckAHRR by in ovo treatment with TCDD. Chicken eggs of 1 embryonic day were treated with vehicle, 1, 10, or 100 pg/g egg of TCDD solution. Eleven to 16 eggs were employed for each dose. Vehicle or TCDD solution was injected as described in the ''Materials and Methods'' section. Chicken embryos were sacrificed before hatching at the 20th day, and livers were removed for total RNA extraction. Expression levels of ckCYP1A5 and ckAHRR mRNAs were quantified with two-step real-time PCR method. Each bar and attached vertical line represent the mean and SD of quantified mRNA levels, respectively. *p < 0.05 compared with solvent control. The interaction between ERa and AHR was also exhibited by Ohtake et al. (2003) . To confirm the interaction of AHR with ERa in chickens, either ckAHR1 or ckAHR2 was overexpressed together with ckERa in LMH cells (Fig. 11A , lane 3 and lane 4). Both ckAHR1 and ckAHR2 led to an elevation of ckAHR-mediated transactivation in E2 þ TCDD-treated cells compared with the response to E2 or TCDD alone. This indicates that increasing amounts of TCDD-activated ckAHR1 and ckAHR2 enhanced the activity of ckERa in the AHR-ERa cross talk. Thus, this delineates that both TCDD-activated ckAHR1 and ckAHR2 interact with E2-activated ckERa, and this direct or indirect interaction leads to an increase in ckCYP1A5 transcriptional activity.
Given these results, the effect of ckAHRR on the AHR-ERa cross talk was also surveyed by a transient transfection of ckAHRR (Figs. 11A and 11B, lane 2) . The result showed that the enhanced luciferase activity by E2 þ TCDD as well as induced activity by TCDD alone were significantly repressed when compared with the activities in no ckAHRR-transfected cells. This indicates inhibitory effects of ckAHRR on the cross talk between AHR-and ERa-mediated pathways.
DISCUSSION
Diversity of the AHR signaling pathway has been characterized in some animals to understand TCDD toxicity.
Only one type of AHR gene, which is clustered into AHR1, exists in mammals (Carver et al., 1994; Ema et al., 1994; Schmidt et al., 1993) , whereas at least two types of AHR genes, designated as AHR1 and AHR2, have been identified in fish Andreasen et al., 2002; Hahn et al., 1997; Karchner et al., 1999; Tanguay et al., 1999; Yamauchi et al., 2005) and birds (Yasui et al., 2004 . Studies on zebrafish AHR clearly demonstrated that AHR2 is a receptor that binds TCDD and can mediate its downstream responses, whereas AHR1, especially AHR1a, responds poorly to TCDD (Prasch et al., 2003; Teraoka et al., 2003) . In chickens, both AHR1 and AHR2 are able to bind TCDD, but only AHR1 mediates TCDD-dependent CYP1A transactivation (Lee et al., 2009) . This implies that AHR-mediated transcriptional regulatory mechanisms of the dioxin target gene CYP1A in avian species may be different from those in fish and mammals. In the AHR/ARNT signaling pathway, one of important factors is AHRR. Recent studies using in vitro system have suggested that AHRR is a negative regulator of AHR (Evans et al., 2008; Karchner et al., 2009; Zimmermann et al., 2008) , although there is limited information on repressive effect of AHRmediated TCDD toxicity by AHRR in vivo (Hosoya et al., 2008; Jenny et al., 2009) . Thus, studies on the AHRR, potential repressor of AHR, especially in nonmammalian species such as avian and piscine models could give a clue to understand the evolutionary history and functional diversity of the AHRmediated signaling pathway. With this background, we have investigated AHRR from the chicken as an avian model animal and found both conserved and unique or novel characteristics of ckAHRR.
First, the tissue distribution pattern of ckAHRR mRNA was unique compared with other animals. In the case of rats, AHRR mRNA expression in male was the most abundant in the intestine and that in female was in the lung (Nishihashi et al., 2006) . On the other hand, in mice, there was no significant difference in tissue distribution pattern between male and female, and heart and brain are the two tissues with its major expression. Hence, our study also supports that AHRR mRNA expression is regulated in tissue-and species-specific manners.
Second, the inducibility of AHRR mRNA by AHR ligand, TCDD, was conserved in the chicken. Previous studies in other vertebrates including the human, rat, mouse, frog, and zebrafish demonstrated the induction of AHRR transcript in response to TCDD, 3-MC, or benzo(a)pyrene in vivo and in vitro systems (Bernshausen et al., 2006; Evans et al., 2005; Huang et al., 2002; Korkalainen et al., 2004; Yamamoto et al., 2004; Zimmermann et al., 2008) . As shown in the present avian study, the induction of AHRR transcript by treatment of AHR ligands is likely to be evolutionarily conserved. Similar TCDD dose-response relationships between CYP1A and AHRRs were observed in the ZF-L zebrafish liver cell line (Evans et al., 2005) . The present and previous studies imply that a shared mechanism on transcriptional regulation of the two genes in AHR/ARNT signaling pathway is conserved in fish and avian species. Thus, TCDD-activated AHR-ARNT complex via XREs may contribute to AHRR mRNA induction in avian species. This can be supported by the findings indicating that putative XREs are located in the promoter or intron 1 region of AHRR from the human, mouse, rat, and killifish (Baba et al., 2001; Haarmann-Stemmann et al., 2007; Karchner et al., 2002; Nishihashi et al., 2006) . Moreover, functional analysis of the XREs identified in mAHRR using in vitro reporter gene assay revealed upregulation of AHRR transcripts by 3-MC via XREs (Baba et al., 2001) . In killifish, AHRR induction by TCDD was AHR dependent (Karchner et al., 2002) .
Third, functional analysis of ckAHRR using transient transfection assays revealed its suppressive role on AHR-mediated transactivation with a similar pattern as the human, mouse, frog, D) and COS-7 cells (E). The indicated amount of wild-type ckAHRR or each deletion mutant was transfected with pGL4-ckCYP1A5-6XREs and pGL4.74[hRLuc/TK] along with ckAHR1 and/or ckARNT1 expression constructs. After vehicle or TCDD (14nM of final concentration) treatment, cell lysates were prepared and used for luciferase assays. Results are given as mean ± SD of two independent experiments performed in triplicate (n ¼ 6).
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and zebrafish (Evans et al., 2008; Karchner et al., 2009; Mimura et al., 1999; Zimmermann et al., 2008) . Hence, we conclude that the suppression mediated by AHRR on AHR/ARNT signaling pathway at least in the in vitro system is conserved in vertebrates including avian species. In zebrafish, which has at least two AHR isoforms (AHR1 and AHR2), as well as in avian species, TCDDactivated AHR2-dependent transactivation was inhibited by AHRR (Evans et al., 2008) . Both avian and fish studies indicate that AHRR may negatively regulate not only AHR1-but also AHR2-mediated signaling pathways.
Intriguingly, the molecular mechanism of ckAHRR action is somewhat different from that in other animals. The dispensability of C-terminus for ckAHRR activity agreed with results of zebrafish AHRR (Evans et al., 2008) . The low identities of sequences in the C-terminal region of AHRRs but its conserved repressive role in AHR-mediated transactivation among species could support the minor contribution of Cterminal region to its repressive activity. However, the effect mediated by the region beyond PAS A of AHRR corresponding to PAS B domain of ckAHR1 was markedly different between the chicken and zebrafish. The deletion mutant of zebrafish AHRRa, AHRRa-D (189-550) remained functional (Evans et al., 2008) in spite of its longer deletion over 24 amino acids than ckAHRR-D(217-756) construct. This implies that the contribution of the region beyond PAS A of AHRR to AHRmediated activity is different across the species. Moreover, the present study showed that the amount of ARNT for the dimerization with AHR is not a limiting factor of ckAHRRmediated repression; the competition between AHR and AHRR for the dimerization with ARNT is not a critical event in the   FIG. 8 . Sequestration of ckARNTs by ckAHRR is not involved in the loss of ckAHR activity mediated by ckAHRR. (A and B) Electrophoretic mobility shift assay. Wild-type (wt) ckAHRR and its deletion mutant ckAHRR-D(403-756) expression plasmids were in vitro translated using T N T rabbit reticulocyte system and incubated with ckARNT1 or ckARNT2 in the presence of 32 P-labeled chicken XRE probe. A 100-fold molar excess of unlabeled XRE probe was added in lanes 4 and 7 of figure B. Mixtures were then separated on a nondenaturing gel. (C) LMH cells were transiently transfected with reporter vectors, pGL4-ckCYP1A5-6XREs and pGL4.74[hRLuc/TK]. Additionally, ckAHR1 expression plasmid (5 ng) was also cotransfected with the expression plasmids of ckAHRR (0 or 100 ng) and the indicated amount of ckARNT1 or ckARNT2 (0 to 150 ng). After 6 h of transfection, cells were treated with vehicle or TCDD (14nM of final concentration). After 24 h incubation, cell lysates were prepared and used for luciferase assays. Results are given as mean ± SD of two independent experiments performed in triplicate (n ¼ 6). 330 LEE ET AL.
repression process. Together with this, we indicated that the alteration of intracellular localization of AHR is not related to ckAHRR action. Other studies have also demonstrated that excess ARNT expression did not rescue AHR-mediated responses suppressed by the human and zebrafish AHRRs (Evans et al., 2008; Karchner et al., 2009) and nuclear translocation of AHR was not blocked by zebrafish AHRR (Evans et al., 2008) . Thus, ARNT sequestration by AHRR as well as modulation of AHR translocation may not be responsible for AHRR-mediated repression in any vertebrate species examined. In aspect of SUMO modification of AHRR, the effect of SUMOylation was not detected in ckAHRR. However, it should be pointed out that in LHM cells employed in this study, there is no information on the presence of SUMOylation pathway such as SUMO, E1 activating enzyme, E2 conjugating enzyme (Ubc9), and E3 ligase. Thus, it is unclear whether less recovery of luciferase activity by the SUMO mutants results from no association of SUMOylation with ckAHRR activity or absence of SUMOylation pathway in LMH cells. To clarify this, the detection of SUMO-modified ckAHRR in LMH cells may be necessary. On the other hand, in case of COS-7 cells, it is known that SUMOylation pathway is conserved (Kishi et al., 2003) . Furthermore, it was shown that mAHRR could be modified by SUMO in COS-7 cells, and the SUMO modification contributed to the repression of AHR-mediated activity (Oshima et al., 2009) . To compare the SUMOylation effect of AHRR between the mouse and chicken, COS-7 cells were also employed in this study and similar results with LMH cells were obtained. Although the reason of this discordance is not clear, the modulation effect of AHRR via its SUMOylation sites FIG. 9 . No effect of mutations of SUMOylation sites on ckAHRR activity in LMH (A) and COS-7 (B) cells. Both cells were transiently transfected with reporter vectors, pGL4-ckCYP1A5-6XREs and pGL4.74[hRLuc/TK], along with the expression plasmid for wild-type ckAHRR or ckAHRR with lysine to arginine mutations in each of three lysine sites, either alone or in combination. In COS-7 cells, ckAHR1 and ckARNT1 expression plasmids were also transfected. After 6 h of transfection, cells were treated with vehicle or TCDD (14nM of final concentration). Following 24 h incubation, cell lysates were prepared and used for luciferase assays. Results are given as mean ± SD of two independent experiments performed in triplicate (n ¼ 6).
FIG. 10.
No alteration of nuclear translocation of ligand-activated ckAHR1 by ckAHRR. In COS-7 cells, expression constructs of 300 ng of EGFP-tagged ckAHR1 (pCXN2-ckAHR1-EGFP) and 50 ng of ckARNT1 (pcDNA-ckARNT1) were transfected without (A, B, and C) or with (D, E, and F) 100 ng of ckAHRR (pcDNA-ckAHRR). The plasmid quantity was adjusted to 400 ng using pcDNA plasmid with no insert. After 5 h, cells were treated with vehicle or 3-MC (1lM) for 12 h, and EGFP was monitored with a fluorescence microscope.
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conserved among species might be not conserved between the two species.
Finally, a positive regulatory cross talk between AHR-and ERa-mediated pathways was observed in the chicken, and a novel role of ckAHRR in the cross talk was uncovered. Ligand-activated ckERa could potentiate transcriptional activity of AHR induced by TCDD, and ckAHRR could inhibit the effect of ckERa. This implies that the mechanism of ckAHRRmediated repression on ckAHR activity is shared with that on ckERa activity. Recently, Kanno et al. (2008) observed direct interaction of AHRR with ERa and repressive effects of AHRR on ERa-mediated transactivation in human breast cancer cells. The interaction between HDACs and AHRR was also demonstrated by Oshima et al. (2007) . This suggests that in an ERa-mediated pathway, AHRR may play a role as a corepressor through interaction with HDACs, resulting in the modification of histone and chromatin structures. Thus, the interaction of ckAHRR with ckAHR, ckERa, and other transcriptional regulators is a key process to account for the repression mechanism.
Taken together, the basic function of AHRR in terms of suppression of AHR-mediated pathway appears to be conserved in a variety of vertebrate species including birds, fish, and mammals, but the critical region of AHRR that is involved in the repressive action and the mode of action may be distinct among these taxa. In addition, it is likely that ckAHRR can repress not only ckAHR activity induced by TCDD but also ckAHR activity potentiated by ckERa through the interference of ckAHR-ckERa cross talk. Because of complex cross talk of AHR with other nuclear receptor-mediated signaling pathways including ERa, the roles of AHRR are not likely to be limited to AHR/ARNT signaling pathway. Further investigation of ckAHRR functions will shed light on understanding of AHR-mediated TCDD toxicity in avian species as well as molecular mechanism of AHRR action.
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